These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24488495)

  • 21. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.
    Yao Z; Xing L; Boyce BF
    J Clin Invest; 2009 Oct; 119(10):3024-34. PubMed ID: 19770515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RelB/NF-κB2 regulates corticotropin-releasing hormone in the human placenta.
    Wang B; Parobchak N; Rosen T
    Mol Endocrinol; 2012 Aug; 26(8):1356-69. PubMed ID: 22734038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
    Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
    Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.
    Bonizzi G; Bebien M; Otero DC; Johnson-Vroom KE; Cao Y; Vu D; Jegga AG; Aronow BJ; Ghosh G; Rickert RC; Karin M
    EMBO J; 2004 Oct; 23(21):4202-10. PubMed ID: 15470505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes.
    Hirata K; Taki H; Shinoda K; Hounoki H; Miyahara T; Tobe K; Ogawa H; Mori H; Sugiyama E
    Biol Pharm Bull; 2010; 33(1):133-7. PubMed ID: 20045951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription.
    Kane LP; Mollenauer MN; Xu Z; Turck CW; Weiss A
    Mol Cell Biol; 2002 Aug; 22(16):5962-74. PubMed ID: 12138205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
    Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
    J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
    Hu JP; Nishishita K; Sakai E; Yoshida H; Kato Y; Tsukuba T; Okamoto K
    Eur J Pharmacol; 2008 Feb; 580(1-2):70-9. PubMed ID: 18083161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placenta.
    Wang B; Palomares K; Parobchak N; Cece J; Rosen M; Nguyen A; Rosen T
    Mol Endocrinol; 2013 Feb; 27(2):203-11. PubMed ID: 23239753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gypenoside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB, AKT, and MAPK signaling pathways.
    Han J; Gao W; Su D; Liu Y
    J Cell Biochem; 2018 Sep; 119(9):7310-7318. PubMed ID: 29797602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
    Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
    Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
    Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
    J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p100 Deficiency is insufficient for full activation of the alternative NF-κB pathway: TNF cooperates with p52-RelB in target gene transcription.
    Lovas A; Weidemann A; Albrecht D; Wiechert L; Weih D; Weih F
    PLoS One; 2012; 7(8):e42741. PubMed ID: 22880094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.